213 related articles for article (PubMed ID: 31177159)
1. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
Haque W; Verma V; Butler EB; Teh BS
Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
[TBL] [Abstract][Full Text] [Related]
2. Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis.
Carroll R; Bortolini M; Calleja A; Munro R; Kong S; Daumont MJ; Penrod JR; Lakhdari K; Lacoin L; Cheung WY
BMC Cancer; 2022 Mar; 22(1):255. PubMed ID: 35264135
[TBL] [Abstract][Full Text] [Related]
3. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
4. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.
Nieder C; Tollåli T; Norum J; Pawinski A; Bremnes RM
Anticancer Res; 2012 Jan; 32(1):189-94. PubMed ID: 22213306
[TBL] [Abstract][Full Text] [Related]
6. Early mortality of stage IV non-small cell lung cancer in the United States.
Amini A; Verma V; Glaser SM; Shinde A; Sampath S; Stokes WA; Rusthoven CG; Massarelli E; Salgia R; Gaspar LE; Liu AK
Acta Oncol; 2019 Aug; 58(8):1095-1101. PubMed ID: 30958075
[No Abstract] [Full Text] [Related]
7. Patterns of care for non-small cell lung cancer patients in Belgium: A population-based study.
Verleye L; De Gendt C; Vrijens F; Schillemans V; Camberlin C; Silversmit G; Stordeur S; Van Eycken E; Dubois C; Robays J; Wauters I; Van Meerbeeck JP
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28833865
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
[TBL] [Abstract][Full Text] [Related]
9. Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.
Haque W; Szeja S; Tann A; Kalra S; Teh BS
Am J Clin Oncol; 2018 Mar; 41(3):259-266. PubMed ID: 26771443
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer.
Perez EA
Chest; 1998 Aug; 114(2):593-604. PubMed ID: 9726750
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
Casebeer A; Antol DD; DeClue RW; Hopson S; Li Y; Khoury R; Michael T; Sehman M; Parikh A; Stemkowski S; Bunce M
J Manag Care Spec Pharm; 2018 Jun; 24(6):554-564. PubMed ID: 29799325
[TBL] [Abstract][Full Text] [Related]
12. Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan.
Kuwabara K; Matsuda S; Fushimi K; Anan M; Ishikawa KB; Horiguchi H; Hayashida K; Fujimori K
Tohoku J Exp Med; 2009 Jan; 217(1):29-35. PubMed ID: 19155605
[TBL] [Abstract][Full Text] [Related]
13. Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012.
Becerra AZ; Probst CP; Fleming FJ; Xu Z; Aquina CT; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Katz AW; Monson JR; Jusko TA
Am J Hosp Palliat Care; 2018 Feb; 35(2):336-342. PubMed ID: 28494653
[TBL] [Abstract][Full Text] [Related]
14. Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.
Goulart BH; Reyes CM; Fedorenko CR; Mummy DG; Satram-Hoang S; Koepl LM; Blough DK; Ramsey SD
J Oncol Pract; 2013 Jan; 9(1):42-50. PubMed ID: 23633970
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
[TBL] [Abstract][Full Text] [Related]
16. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
[TBL] [Abstract][Full Text] [Related]
17. The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.
Zeng X; Karnon J; Wang S; Wu B; Wan X; Peng L
PLoS One; 2012; 7(10):e48323. PubMed ID: 23118985
[TBL] [Abstract][Full Text] [Related]
18. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
Tsai HY; Chung KP; Kuo RN
J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
